Regenerative Medicine Market Poised to Garner Maximum Revenues During 2018 - 2026

Regenerative Medicine Market Poised to Garner
Maximum Revenues During 2018 - 2026
Regenerative Medicine Market – Global Industry Insights, Trends, Outlook, and
Opportunity Analysis, 2018-2026
Regenerative medicines are medical products or active pharmaceutical ingredients that have the ability
to cure or replace organs and tissues organs damaged by various factors such as aging, diseases,
trauma, and can also be used to provide stability in congenital disorders. According to findings of
various studies, regenerative medicines can also be useful in treating both chronic and acute disorders
in terms various context of abnormalities such as cardiovascular diseases, dermal wounds, and in
treatment of certain types of cancer. Furthermore, the current therapy of organ and tissue
transplantation for treating organ and tissue failures can result in patient death due to limited or no
donor supply and often result in severe complications in immune system. Regenerative medicine helps
alleviate such issues to a major extent. Click To Read More On Regenerative Medicine Market.
Furthermore, players in the regenerative medicine market focus on fueling growth in the
pharmaceutical sector by adopting various strategies such as including the use of different materials in
the preparation that can offer better results and newly generated cells or with the combination of both,
in turn replacing the missing tissue and effectively serving its functions. The innate healing response of
the human body can also be favored to support the regenerating activities. Age is a major factor that
can affect the regeneration of the desired part, as the body’s ability to regenerate is low among adults as
compared to young population or lower vertebrates. Materials play an important role in regeneration
activities, as they form the basis of the growth and replacement, as they can mimic the native
extracellular matrix (ECM) of tissues.
Ask For Sample Copy Of This Business Research Report :
https://www.coherentmarketinsights.com/insight/request-sample/163
Rising number of bone and joint surgeries to fuel the growth of regenerative medicine market in
the near future:
Rise in number of trauma case globally is expected to favor growth of the regenerative medicine
market in the near future. There are different types of prosthetics and implants that are used to support
the human body movement in case of trauma and severe injury. However, a majority of the young
population perceives these to be an eye sore and are increasingly inclined towards non-obtrusive
options that do not drastically alter their physical appearance and activities. Regenerative medicine
provides a viable alternative to such conventional methods and also reduces risk of deformity.
However, regenerative medicine is significantly expensive as compared to conventional methods of
treatment. Also, this treatment option is barely effective for treatment of the geriatric population. These
factors impede growth of the market to a certain extent.
Major acquisitions to support growth of regenerative medicine market
There are few recent acquisitions by the big brands in biotechnology that is expected to favor growth of
regenerative medicine industry. In August 2016, Medtronic Inc. acquired Heart Ware International, Inc.
— a provider of technologies for less-invasive, miniaturized, mechanical circulatory support (MCS) for
treatment of patients with advanced heart failure. This acquisition is further expected to favor the
working efficiency of the company and broadens its product portfolio. Key players operating in the
regenerative medicine market include Depuy Synthes, Inc., Orthofix, Inc., NuVasive, Inc. and Zimmer
Holdings, Inc.
Developed regions major growth engines of the regenerative medicine market
Developed countries such as the U.S., Germany, U.K., France, and Japan have a highly developed
market for regenerative medicine, mainly due to technical advancements in the region. According to
Regenerative Medicine Annual Report, in 2013, in regenerative medicine market there has been various
product approvals along with annual revenue of around US$ 1 billion. Thus, this sector is expected to
attract attention from investors and industry partners in the near future. Furthermore, as per the report,
around 60,000 stem cell transplants are performed globally each year to treat various cancers and
blood-based disorders. This augments growth of the market of regenerative medicine. Also, as observed
by Alliance for Regenerative Medicine (ARM), in 2012, the bio-therapeutic companies distributing cell
therapy products generated around US$ 900 million, with 160,000 patients undergoing various related
treatments.
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready
syndicated research reports, custom market analysis, consulting services, and competitive analysis
through various recommendations related to emerging market trends, technologies, and potential
absolute dollar opportunity.
Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1–206–701–6702
Email: sales@coherentmarketinsights.com

Regenerative medicines are medical products or active pharmaceutical ingredients that have the ability to cure or replace organs and tissues organs damaged by various factors such as aging, diseases, trauma, and can also be used to provide stability in congenital disorders.

Download Report